Last month three ݮƵ Imperial BRC researchers received awards for research and utilisation of mass spectrometry in clinical practice at the annual MSACL (Mass Spectrometry: Applications to the Clinical Lab)ԳٱԲپDzԲcongress. MSACL annualپԲbrings together academic and industrial experts in the field of mass spectrometry to discuss its clinical applications in order to improve patients’ care and treatment.

" />

ݮƵ

Imperial investigators receive international recognition for phenomics research

MSACL_tiny
Image credit: Bryan Reinhart Photography

Last month three ݮƵ Imperial BRC researchers received awards for research and utilisation of mass spectrometry in clinical practice at the annual MSACL (Mass Spectrometry: Applications to the Clinical Lab)ԳٱԲپDzԲcongress. MSACL annualپԲbrings together academic and industrial experts in the field of mass spectrometry to discuss its clinical applications in order to improve patients’ care and treatment.

ٰPetra Paizs, a PhD student within the MolecularPhenomicsTheme, delivered a talk on her work in optimising analysis of faecal metabolitesinpatients with colorectal cancer andinflammatory bowel disease,which was recognised witha Young Investigator Grant.

Dr PanagiotisVorkas,investigatorin the MolecularPhenomicsand Gut Health Themes,presentedhisresearch intobiomarker discoveryfor active and advancing atherogenesis,which was supported by a travel award from MSACL.

And Professor ZoltanTakats, MolecularPhenomicsTheme Lead and Director of the National Phenome Centre, was recognised with the prestigious MSACL Distinguished Contribution Award for his outstanding achievements in research and application of clinical mass spectrometry. He delivered a keynote lecture at the congress, titled “15 years of Ambient Mass Spectrometry: From Amino Acid Clusters to Surgical Robotics”.

Our Molecular PhenomicsThemeforms part ofthe National Phenome Centre– aunique resourceavailable toallresearcherswho would like to applymetabolic profiling techniques for personalised medicine.